The new European pharmacovigilance legislation is the biggest regulatory change to how the industry develops human medicine since 1995. Through our intense industry research Health Network Communications has put together a conference which will summarise all the new sets of guidelines for the conduct of pharmacovigilance in the EU from July 2012.
Overcome the challenges you will face by meeting with the top senior safety executives from all the major pharma in Europe. Download your brochure now for the World Drug Safety Congress Europe 2012 conference and learn how to gain a competitive edge in the market!
Speakers include; Dr Ennis Lee, Johnson & Johnson, Dr Craig Hartford, Pfizer, Dr Vicki Edwards, Abbott, Mick Foy, MHRA, Dr Ralph Nies, Astellas, Dr Gro Laier, Novo Nordisk, Dr Ute Hoeffner, Novartis and many more!